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HIGHLIGHTS 
 
 Neuronal networks were explored in patients with cirrhosis using advanced EEG computational 
analysis. 
 Significant disruption of cortical networks was found even in the absence of hepatic 
encephalopathy. 
 The findings provide new insights into the cortical signature of this syndrome and its 
pathogenesis. 
 
ABSTRACT 
Objective: Hepatic encephalopathy is a common complication of cirrhosis; it is characterised by 
neuropsychometric/neurophysiological abnormalities.  Its pathophysiology is complex but glial 
neuronal communication is likely to be disrupted and to impact on oscillatory networks and cortical 
connectivity.  The aim of this study was to use multichannel electroencephalography (EEG) to 
investigate functional connectivity, as a surrogate for cortical networks, in patients with cirrhosis. 
Methods: Resting EEGs were recorded in 98 healthy controls and in 264 patients with cirrhosis 
characterised psychometrically using the Psychometric Hepatic Encephalopathy Score (PHES).  
Functional connectivity was calculated using the phase-lag index with stratification into standard EEG 
frequency bands.  The findings were validated in a further cohort of 39 healthy controls and 106 
patients with cirrhosis. 
Results: Widespread disruption in functional connectivity was observed in the patients compared with 
the controls; connectivity was increased in the theta (4-8 Hz) band and decreased in the delta (1–3.5 
Hz), alpha (8.5–13 Hz) and beta (13.5–26.5 Hz) bands.  Changes were apparent even in patients who 
were psychometrically unimpaired compared with healthy controls viz mean ± SEM theta 0.107±0.001 
vs. 0.103±0.002 (p<0.05) and alpha.0.139±0.003 vs. 0.154±0.003 (p<0.01); more pronounced changes 
were observed with increasing neuropsychometric impairment.  Findings were replicated in the 
second cohort. 
Conclusions: Cortical networks are disturbed in patients with cirrhosis even in the absence of 
psychometric impairment.   
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Significance: These findings will facilitate further exploration of the pathophysiology of this condition 
and provide a robust means for assessing treatment effects in research settings.  
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1. Introduction 
 
The term 'hepatic encephalopathy' is used to describe the spectrum of neuropsychiatric change which 
commonly complicates the course of cirrhosis (Vilstrup et al., 2014).  People with cirrhosis with 
clinically apparent impairment in mental and motor performance, for which there is no other 
discernible cause, are classified as having overt hepatic encephalopathy.  Those with no apparent 
clinical neuropsychiatric deficits who nevertheless show neuropsychometric or neurophysiological 
abnormalities are classified as having minimal hepatic encephalopathy (Vilstrup et al., 2014).  This 
condition, whether minimal or overt, significantly compromises patients’ activities of daily living, their 
quality of life, their safety and their survival (Bustamante et al., 1999; Groeneweg et al., 1998; Roman 
et al., 2011; Schomerus et al., 1981).  It also poses a substantial burden for the carers of those affected 
(Bajaj et al., 2011) and a significant financial burden on healthcare systems (Stepanova et al., 2012). 
The pathogenesis of hepatic encephalopathy is unknown although several important components of 
the complex underlying process have been identified (Häussinger and Sies, 2013).  Ammonia plays a 
key role via induction of astrocyte swelling and the development of low-grade cerebral oedema.  
Astrocyte dysfunction results in alterations in gene expression, modification of proteins and RNA, and 
disturbances in intracellular signal transduction and neurotransmission.  As a result, glial-neuronal 
communication is disrupted and this likely impacts on synaptic plasticity, oscillatory electric networks 
and brain connectivity (Häussinger and Sies, 2013).  
Recently, resting-state functional magnetic resonance imaging (fMRI) has been used to study 
functional connectivity, or the intrinsic coherence of neural activity, between distinct brain regions in 
patients with cirrhosis (Chen et al., 2013, 2015, 2016; Hsu et al., 2012; Jao et al., 2015; Qi et al., 2012).  
Overall, these studies have identified a ‘stepwise’ deterioration in functional brain networks with 
increasing degrees of psychometric impairment.  However, the number of patients included in these 
studies is small; the exact number is unclear because there is acknowledged overlap of patients 
between studies but the total does not exceed 200.  The majority of patients included in the fMRI 
studies had minimal hepatic encephalopathy; less than 20 had overt hepatic encephalopathy (Hsu et 
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al., 2012; Jao et al., 2015).  Technical difficulties and costs are likely to be the main limiting factors.  
fMRI does not provide a direct measure of neuronal oscillations but rather an indirect measure based 
on changes in blood oxygenation, which may limit, to some extent,  the interpretation of the findings.  
Electroencephalography (EEG), in contrast to fMRI, provides direct information on cortical neuronal 
activity; it has been used to detect, assess and monitor hepatic encephalopathy since the 1950s (Foley 
et al., 1950; Marchetti et al., 2011; Montagnese et al., 2004; Parsons-Smith et al., 1957).  The main 
electrophysiological characteristic of hepatic encephalopathy is slowing of the mean frequency from 
the alpha range (8.5-13 Hz) towards the theta (4-8 Hz) and delta (1-3.5 Hz) ranges (Jackson et al., 
2016).  
Recent developments in the field of EEG analysis and computational science have allowed 
investigation of neuronal networks via the functional connectivity between brain areas.  This 
assessment is based on the phase-relationships between the EEG signals from spatially dispersed scalp 
electrodes representing cortical networks of synchronised neurons.  Several methods exist to estimate 
functional connectivity based on the premise that electrodes with similar phase will exchange 
information (Fig. 1).  The phase-lag index (PLI) is a relatively new method for assessing functional 
connectivity.  In contrast to other methods, it obviates the ‘common source problem’ which may give 
rise to spurious correlations between time series (Nolte et al., 2008; Stam et al., 2007).  Use of PLI may 
provide new insights into the cortical signature of hepatic encephalopathy and hence the 
pathogenesis of this syndrome.   
The aims of this study were to investigate: i) EEG functional connectivity, and its cortical topography, 
in a cohort of patients with cirrhosis with or without neuropsychiatric impairment and to validate the 
findings in a second independent cohort; and, ii) the associations between EEG functional connectivity, 
psychometric performance, and the aetiology and severity of the underlying liver disease 
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2. Methods  
2.1. The discovery population 
The discovery population comprised of 264 patients with biopsy-proven cirrhosis (172 men: 92 
women: mean [range] age 55.7 [24-80] years), recruited at the Royal Free Hospital, London between 
2008 and 2016.  The aetiology of the liver injury was determined using clinical, laboratory, radiological 
and histological variables; its severity was assessed using the model for end-stage liver disease (MELD) 
score and Pugh’s modification of the Child’s grading system (Pugh et al., 1973).  Patients were 
excluded if they were <20 or >80 years of age; if they had hyponatraemia or renal failure; significant 
cardiac or respiratory failure; Type I diabetes mellitus or Type II diabetes with poor glycaemic control; 
cerebrovascular disease; epilepsy; a history of significant head injury or other conditions likely to 
affect cerebral function.  Patients were also excluded if they had a surgically created or transjugular 
intrahepatic portal systemic shunt; had misused alcohol or drugs in the previous three months or were 
taking psychoactive medication.  All patients were clinically stable at the time of the study.   
 
2.2. The validation population 
The validation population comprised of 106 patients with cirrhosis (72 men: 34 women; mean age 
49.2 [19-69] years) recruited from the Department of Medicine in Hannover, Germany between 2008 
and 2011.  The exclusion criteria were those utilized for selection for liver transplantation which are 
broadly similar to those applied in UK patient cohort.  
2.3. The healthy reference population 
The healthy reference population comprised of 137 healthy individuals (73 men: 94 women; mean age 
39.2 [17-75] years) recruited from family, friends and staff working at the Royal Free Hospital, London 
or else individuals who had experienced an isolated episode of fainting/dizziness but in whom clinical 
examination, the EEG, and cerebral imaging were normal at baseline and during prolonged follow-up.  
None of the included individuals had a history of liver disease, drank alcohol in excess of 20 g daily, or 
took prescription or over-the-counter medications.  
2.4. Study procedures 
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Each UK participants was assessed in a single session lasting approximately two hours.  Psychometric 
testing was undertaken in a quiet well-lit room; tests were presented in the same order, using a 
standard set of instructions from scripted texts.  The EEGs were performed in a dedicated recording 
room by a trained neurophysiologist.  The German participants were assessed using similar 
procedures and test conditions to those used in the UK.   
 
2.4.1. Psychometric assessment:  
Psychometric performance was assessed using the Psychometric Hepatic Encephalopathy Score 
(PHES) battery (Weissenborn et al., 2001), which comprises of five paper and pencil tests viz: number 
connection A and B; digit symbol; serial dotting; and line tracing.   
 
The raw PHES data collected in the UK were adjusted and scored using UK normative values; 
composite scores of less than two standard deviations below mean reference values were considered 
abnormal (Marks et al., 2008).  For purposes of this study patients were ranked by their composite 
final score as follows: PHES >0; PHES 0 to -2; PHES -2 to -4; and PHES <-4 (Marks et al., 2008).  
 
The raw PHES data collected in Germany were adjusted and scored using German normative reference 
data (Weissenborn et al., 2001); the final PHES score comprised the sum of the Z-scores of the 
individual tests and was considered abnormal if less than -4.  For purposes of this study patients were 
ranked by their composite final score as follows: PHES >0; PHES 0 to -4; PHES -4 to -8; and PHES <-8. 
2.4.2. EEG recording:  
EEGs were recorded, in the UK, using one of two digital EEG systems viz. Walter-Graphtek PL-Winsor 
(Walter-Graphtek GmbH, Emmendingen, Germany) or MicroMed SystemPlus EVOLUTION (Micromed 
Sp.A., Mogliano, Veneto, Italy).  Recordings were undertaken for 6-10 min, in a state of eyes-closed, 
relaxed, wakefulness, using 23 silver-silver chloride electrodes placed according to the International 
10-20 System.  The sampling rate was 256 Hz/s with the online band filter set at 0.05 to 70.0 Hz.  The 
impedance of the electrodes was kept below 5 KΩ.   
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EEGs were recorded in Germany using a Walter-Graphtec digital EEG recording system (Walter-
Graphtek GmbH, Emmendingen, Germany), under similar conditions to those employed in the UK.  
The data were exported and dispatched to the Department of Clinical Neurophysiology, at the Royal 
Free London NHS Foundation Trust, for further computational processing. 
2.4.3. EEG analysis: 
2.4.3.1. EEG pre-processing: A consecutive, 60–100s of eyes-closed, artefact-free recording was 
 selected from the P3-P4 derivation (Marchetti et al., 2011).  If the length of artefact-free 
 recording available for analysis was insufficient, the selection criteria were relaxed to allow 
 use of a combination of artefact-free sections from the same derivation. 
2.4.3.2. Spectral EEG analysis:  The preselected 60–100s of recording was divided into two second 
 epochs and multiplied with a cosine window with a one second overlap.  Fast Fourier 
 transform was applied to obtain the spectral power in each 0.5 Hz bin; this was averaged 
 across all epochs to give an average power spectrum for each EEG.  Spectral estimates were 
 obtained for the mean dominant frequency (MDF), which is the weighted mean of 
 frequencies in the 1 to 26.5 Hz range, and the relative power percentages in the 
 standardized frequency bands viz: delta (1–3.5 Hz), theta (4–8 Hz), alpha (8.5–13 Hz) and 
 beta (13.5–26.5 Hz) (Montagnese et al., 2007). 
2.4.3.3. Functional connectivity analysis:  The PLI was calculated using the Neurophysiological 
Biomarker Toolbox (NBT) (http://www.nbtwiki.net/) on a 19 channel average reference 
montage based of the International 10-20 System omitting the A1 and A2 mastoid electrodes.  
The EEG signal was band passed into four frequency bands viz: delta (1–3.5 Hz), theta (4–8 Hz), 
alpha (8.5–13 Hz) and beta (13.5–32.0 Hz): using first-order Butterworth filters (Lehembre et 
al., 2012) and was then divided into two second epochs.  The PLI was calculated for each 
epoch as an asymmetry index of the phase difference distribution obtained from the EEG 
signal (Stam et al, 2007); individual epoch values were then averaged to provide a measure of 
functional connectivity for the full EEG recording.  PLI values range between 0 and 1.  A PLI of 
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0 indicates either no coupling or coupling with a phase difference centered on 0.  A PLI of 1 
indicates perfect phase locking; the stronger the non-zero phase locking the larger the PLI.   
 
2.5. Data processing: creation of the discovery and validation cohorts 
Healthy reference data were not collected in Germany.  Thus, the 137 EEGs collected from healthy 
individuals in the UK were divided to provide independent control data sets for both the UK and 
German patient populations.  The 137 EEGs were first ordered by sex and EEG MDF and then 
individually assigned to either the discovery or the validation cohorts, maintaining the same 
proportionate distribution as in the patients.  Thus, the discovery cohort comprised of 264 patients 
and 98 healthy controls while the validation cohort comprised of 106 patients and 39 healthy controls. 
 
2.6. Statistical analysis 
The distribution of variables was assessed by visual inspection of QQ-plots; the assumption of variance 
homogeneity was checked using Bartlett's test.  The potential confounding effects of age and sex on 
functional connectivity variables were assessed in the reference population using linear regression and 
the necessary adjustments applied to the patients’ connectivity variables prior to statistical analysis.  
Differences between normally distributed spectral EEG variables, clinical and demographic 
characteristics, as well as psychometric tests, were examined by one-way ANOVA and Chi-squared 
tests, as appropriate.  Differences between non-normally distributed variables were examined using 
the Kruskal-Wallis test or Dunn’s pair wise comparison test.   
 
To aid interpretation of the topographical information contained in the multichannel EEG, average 
functional connectivity was calculated for five distinct cortical regions viz. frontal, temporal, central, 
parietal and occipital, by averaging the connectivity estimates from the corresponding EEG electrodes.  
The association between functional connectivity and psychometric test performance, based on 
ranking of the final composite PHES score, was assessed using a linear mixed effects models fitted by 
maximum likelihood estimation with topographic information included in the models as a random 
effect.  The association between functional connectivity, psychometric performance, assessed by the 
raw PHES score, and the severity and aetiology of the underlying liver disease was assessed using 
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linear mixed effect models; topographical information was again included as a random effect in the 
models.  
 
Pearson’s coefficient was used for correlation analysis of functional connectivity and spectral EEG 
estimates.  Reported P-values were two-tailed; values ≤0.05 were considered statistically significant; 
the Bonferroni adjustment was applied for the topographical analysis to account for multiple 
comparisons.  The software packages STATA version 14.1 (StataCorp LP, College Station, Texas) and R 
version 3.0.2 (CRAN.R-project.org/doc/FAQ/R-FAQ.html) were utilized. 
 
2.7. Ethical considerations 
The study was conducted according to the Declaration of Helsinki (Hong Kong Amendment) and Good 
Clinical Practice (European guidelines).  The protocol was approved by the Royal Free Hampstead NHS 
Trust Ethics Committee, London UK and the Ethics Committee of Hannover Medical School, Hannover, 
Germany.  All participating subjects, or their appropriately appointed guardians, provided written, 
informed consent. 
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3. Results 
3.1. The discovery cohort 
The aetiology of the cirrhosis was alcohol in 177 (67.1%) of the 264 patients, alcohol and hepatitis C 
virus (HCV) infection in 21 (8.0%), cryptogenic in 14 (5.3%), fatty liver disease in 16 (6.0%), HCV/HBV 
infection in ten (3.8%), primary biliary cholangitis in six (2.3%), autoimmune hepatitis in eight (3.0%), 
haemochromatosis in four (1.5%) and ‘other aetiologies’ in eight (3.0%) (Table 1).  On the day of study 
42 (15.9%) patients had a PHES score >0; 132 (50.0%) a score of 0 to -2; 75 (28.4%) a score of -2 to -4 
and 15 (5.7%) a score of <-4 (Table 1).  The degree of hepatic decompensation, evidenced by the 
MELD scores, increased with the degree of psychometric impairment (Table 1).   
 
3.2. EEG analysis 
A total of 264 EEGs were recorded in the patient discovery population and 98 in the reference 
population.  None of the EEGs was discarded because of abnormal focal activity; analysable data were 
available from all recorded EEGs. 
 
3.2.1. Spectral EEG estimates  
Progressive abnormalities of the EEG were observed in the patients with cirrhosis with increasing 
psychometric impairment (Supplementary Table 1); this was characterized by overall slowing as a 
result of increased low frequency (delta and theta) activity and decreased high frequency (alpha and 
beta) activity.  The most significant changes were observed in the patient with a PHES score of <-2. 
 
3.2.2. Functional connectivity  
Mean connectivity in the theta band was significantly higher in the patients with cirrhosis than in the 
reference population, whilst mean connectivity in the delta, alpha and beta band was significantly 
decreased (Table 2).  Significant correlations were observed between spectral EEG and functional 
connectivity parameters in all but the beta band (Pearson`s correlation coefficients 0.35-0.70; 
p<0.001); the strongest relationships were observed in the theta and alpha bands (Supplementary 
Table 2).    
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3.3. Functional connectivity, by psychometric performance   
Widespread differences were observed in functional connectivity in the patients with cirrhosis, across 
frequency bands, in relation to psychometric performance (Fig. 2; Table 2).  No significant changes 
were observed in the subgroup of patients with a PHES score >0 but significant changes were 
apparent in the subgroup with PHES scores between 0 and -2.  More pronounced changes, 
characterized by increased theta connectivity and decreased connectivity in the remaining frequency 
bands were observed with increasing psychometric impairment; the exception being a ´secondary 
increase´ of delta connectivity in patients with a PHES score of <-4 (Fig. 2; Table 2).  
 
3.4. Functional connectivity by psychometric performance and EEG topography 
There were significant topographical differences between functional connectivity parameters in the 
patients with cirrhosis, in relation to their psychometric performance (Supplementary Table 3).  The 
most prominent feature was the gradual replacement of frontal connectivity in the alpha band with 
increasing connectivity in the theta band, as the degree of psychometric impairment increased (Fig. 3). 
 
3.5. Univariate and multivariate analyses for associated variables 
On univariate analysis, functional connectivity was progressively reduced in the alpha and beta bands 
with increasing psychometric impairment, while an inverse relation was seen with the theta band 
(Table 3).  The MELD score was significantly associated with functional connectivity in the theta and 
alpha bands, but there were no associations between functional connectivity and the aetiology of the 
liver disease in any of the frequency bands (Table 3). 
 
Multivariate analysis confirmed the independence and significance of these associations viz. PHES 
score and functional connectivity in the theta band (coefficient = -0.003; p <0.001), alpha band 
(coefficient = 0.007; p<0.001) and beta band (coefficient = 0.001; p<0.001); MELD score and functional 
connectivity in the alpha band (coefficient -0.001; p<0.001) (Table 3). 
 
3.6. The validation cohort 
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The aetiology of the liver disease in the 106 German patients was predominantly non-alcohol-related 
viz HCV infection in 38 (35.8%); primary sclerosing cholangitis in 23 (21.7%); cryptogenic in 11 (10.4%); 
chronic HBV infection in six (5.7%); polycystic liver disease in five (4.7%); chronic active hepatitis in 
four (3.8%); alcohol in two (1.9%) and ‘other aetiologies’ in 17 (16.0%).  The mean MELD score was 
12.3 (5.6-23.6).  On the day of study 30 (28.3%) patients had a PHES score >0; 47 (44.3%) a score of 0 
to -4; 16 (15.1%) a score -4 to -8 and 13 (12.3%) a score of <-8. 
 
A total of 106 EEGs were recorded in the patient validation population and 39 in the allocated 
reference population.  None of the EEGs was discarded because of abnormal focal activity; analysable 
data were available from all the recorded EEGs. 
 
The widespread changes in functional connectivity observed in the discovery population, in relation to 
psychometric performance, were replicated in the validation population (Fig. 4; Supplementary Table 
4).  In particular: (i) the evident changes in functional connectivity within a subgroup of patients in 
whom psychometric performance would ordinarily be considered unimpaired viz PHES score 0 to -4; 
and, (ii) the progressive increase in theta connectivity and further decreases in connectivity in the 
remaining frequency bands with increasing psychometric impairment, except, in this instance, within 
the delta band (Fig. 4; Supplementary Table 4).   
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4. Discussion  
 
In the present study, brain networks were investigated, using multichannel EEG and the surrogate 
variable functional connectivity, in a large well-characterized population of patients with cirrhosis with 
varying degrees of neuropsychometric impairment.  Widespread disruption was observed even in 
patients in whom psychometric performance was unimpaired; further disruption was observed with 
increasing deterioration in psychometric performance.  The disruption in functional connectivity was 
positively associated with the severity of the underlying liver disease but not its aetiology.  The main 
findings were validated in a second independent cohort of patients; in particular the presence of 
disrupted functional connectivity, in the absence of psychometric impairment, was again observed, as 
was the progression of the disruption with increasing psychometric impairment.  Moderate to strong 
correlations were observed between spectral EEG and functional connectivity variables, particularly in 
the theta and alpha bands, but these were not absolute.  Thus, the assessment of connectivity 
provides complementary information not captured by conventional EEG examination based on 
spectral analysis. 
 
4.1. Functional connectivity and psychometric performance 
A clear and progressive disruption in functional connectivity was observed, in the patients with 
cirrhosis, with increasing psychometric impairment.  There are no comparable EEG studies with which 
to compare these findings.  Marchetti et al. (2011) examined EEG coherence, as a measure of 
functional interaction, in a large group of patients with cirrhosis and found an association between 
increasing cognitive impairment and higher frontal-to-parietal and posterior inter-hemispheric 
coherence within the theta band.  However, coherence is sensitive to volume conduction through the 
cortical membranes, scalp and skin, which may bias the assessment (Marchetti et al., 2011; Stam et 
al., 2007)   
 
Functional cortical connectivity has been studied in patients with cirrhosis and varying degrees of 
psychometric impairment using resting state fMRI (Chen et al., 2013, 2015, 2016; Hsu et al., 2012; Jao 
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et al., 2015; Qi et al., 2012).  The results of these studies, which were undertaken in China and Taiwan, 
have been published in serial papers with acknowledged overlap of patients between studies.  The 
majority of included patients had hepatitis B-related cirrhosis and their neuropsychiatric status was 
assessed simply by clinical examination and use of a small number of psychometric tests.   
The Chinese group confined their studies to patients with cirrhosis who were psychometrically 
unimpaired or who had minimal hepatic encephalopathy (Chen et al., 2013, 2015, 2016; Qi et al., 
2012).  Neurocognitive networks were found to be atypical (Chen et al., 2016) with a progressive trend 
for increased disruption with worsening psychometric performance (Chen et al, 2013, 2015, 2016; Qi 
et al., 2012).  The effects showed regional specificity (Qi et al., 2012) and regional heterogeneity in 
relation to their correlation with psychometric performance (Chen et al., 2013).   
The Taiwanese group also found disrupted brain network organization in patients with cirrhosis and 
an increase in the network disruption with greater neuropsychometric impairment (Hsu et al., 2012; 
Jao et al., 2015).  Similar functional network randomization has also been observed in conditions such 
as Alzheimer’s disease (Stam et al., 2009), epilepsy (van Dellen et al., 2009), and traumatic brain injury 
(Nakamura et al., 2009), suggesting that it might represent a final common pathway for several brain 
pathologies.  Thus, this feature would appear to be a sensitive marker for neuropsychiatric disease, 
but it lacks specificity.  The Taiwanese group also reported that patients with cirrhosis show a 
reduction in both global and nodal connectivity strength; this is a feature of brain disintegration and 
has been observed in both fMRI and EEG studies in propofol-induced anaesthesia (Schröter et 
al.,2012), analgesia with sedation (Khodayari-Rostamabad et al., 2015), sleep (Massimini et al., 2005), 
and coma (Crone et al., 2018).   
Thus overall the results of the fMRI studies confirm the findings in the present study that cortical 
networks are disrupted in patients with cirrhosis and that the degree of disruption correlated with the 
degree of psychometric impairment. 
4.2. Functional connectivity and the severity and aetiology of the liver disease 
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The degree of disruption of functional connectivity observed in the present study increased with 
deteriorating liver function.  In the multivariate analysis, the MELD score was independently 
associated with the functional EEG connectivity measures in the alpha band.  This is to be expected as 
hepatic encephalopathy is associated with, and is a feature of, a reduction in hepatic functional 
reserve.  Marchetti et al., (2011), also found a significant relationship between EEG coherence and the 
degree of liver injury.   
 
No association was observed between the aetiology of liver disease and functional EEG connectivity 
parameters.  This contrast with a previous EEG study which showed an increase in beta activity in 
patients with alcohol-related cirrhosis, possibly reflecting changes in gamma aminobutyric acid (GABA) 
neurotransmission (Olesen et al., 2016).  Variations in the GABA alpha-2 gene are strongly associated 
with the beta frequency of the human EEG and genetic studies have provided evidence of involvement 
of the GABA system in the susceptibility to develop alcohol dependence through an effect on neural 
excitability (Lydall et al., 2011; Saletu-Zyhlarz et al., 2004).  However, alcohol per se modulates 
GABAergic neurotransmission resulting in an increase in the beta activity in the EEG in people actively 
consuming alcohol (Anstee et al., 2013).  Thus, spectral EEG estimates must be evaluated carefully in 
the context of alcohol-related cirrhosis; the increased activity in the high frequency range observed in 
this patient group may compromise the reliability and validity of spectral thresholds (Olesen et al., 
2016).  The functional EEG measures presented in the present study are likely to provide a more 
robust and reliable tool for assessment of the neurophysiological abnormalities associated with 
hepatic encephalopathy in the context of alcohol-related cirrhosis.  This was further illustrated by the 
lack of association between spectral and functional connectivity parameters in the beta band.  
 
4.3. Study strengths and limitations 
This study has a number of strengths: (i) the inclusion of patients with a wide spectrum of 
neuropsychometric abnormalities.  The acquisition of EEG data does not rely on patient cooperation 
whereas patients cooperation is mandatory when using technique which involve task performance or 
experimental manipulation; thus, less than 10% of the patients with cirrhosis studied using fMRI, to 
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date, had evidence of overt hepatic encephalopathy whereas these patients comprised 31 % of the UK 
and 15% of the German populations in the present study; (ii) the discovery population was large and 
well-characterized.  This allowed for detailed stratification and analysis of subgroups with 
documentation of subtle changes in brain function that would not have been detected using 
psychometric testing and conventional normative thresholds.  The large sample sizes, in addition, 
allowed for a detailed analysis of possible confounding factors including age, sex and the severity and 
aetiology of the liver Injury; (iii) an independent validation population of equally well-characterized 
patients was included allowing the main study findings to be ratified; and, (iv) the technique used for 
assessing functional connectivity is not sensitive to volume conduction which is a problem with other 
assessment techniques, such as, coherence. 
 
The study is also limited primarily because: (i) its cross-sectional design does not allow causal 
inferences to be made about the relationship between psychometric performance and the functional 
EEG measures; (ii) its design does not allow determination of the point at which the changes in 
functional connectivity translate into clinically meaningful deficits in neuropsychiatric performance.   
 
The main purpose of this study was to gain insight into cortical processing networks in patients with 
cirrhosis with and without documented neuropsychometric abnormalities.  It was not designed to 
identify variables that could be used diagnostically.  Acquisition of EEG data is relatively easy but the 
connectivity processing is complex and time expensive.  Thus, although it would be possible, with 
further investment, to identify thresholds for assessing cortical network disruption, it is highly unlikely 
that the technique would have utility in the clinical setting although it has potential for use in the 
research setting.   
 
In conclusion: cortical networks are disturbed in patients with cirrhosis even in the absence of 
psychometric impairment; these findings could provide further insights into the pathophysiology of 
the hepatic encephalopathy and, with further investment, a robust and objective mean for 
researching treatment effects. 
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 Legends to Figures: 
Figure 1: The principle behind measurement of functional connectivity using the phase-lag index  
 
The signal from the receiving electrode (blue) is phase-shifted compared to the signal from the driving 
electrode (red). This indicates a strong connection between the two electrodes and hence networks of 
synchronized neurons.  
 
Figure 2: Electroencephalogram functional connectivity in the discovery cohort, by neuro-
psychometric performance, stratified by the PHES score   
 
Data are expressed as estimates from linear mixed models ± SEM.  
 
PHES Psychometric Hepatic Encephalopathy Score.  
 
Significance of the difference between the reference population and the various patient subgroups;  
* p<0.05; ** p<0.01; *** p<0.001. 
 
The significances of the differences between the subgroups of patients with by PHES score are not 
indicated (see Table 2 for details). 
 
Figure 3: Average head maps showing the spatial distribution of functional connectivity estimates in 
the discovery cohort, by neuropsychometric performance, stratified by the PHES score   
 
The raw PHES data were adjusted and scored using UK normative values; a PHES score <-2 was 
considered abnormal using conventional thresholds. 
 
Figure 4:  Average head maps showing the spatial distribution of functional connectivity estimates 
in the validation cohort, by neuropsychometric performance, stratified by the PHES score 
   
The raw PHES data were adjusted and scored using German normative values; a PHES score <-4 was 
considered abnormal using conventional thresholds. 
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Table 1: Demographic and assessment variables in the patient discovery population, by performance on the PHES battery and its components. 
 
 
Data are expressed as mean ± 1SD (range) or absolute number (%). 
 
HE: hepatic encephalopathy; MELD: model for end-stage liver disease; NCT-A/B, Number Connection Tests A/B; DS: Digit Symbol Test;  
LT-T/E: Line Tracing Test-Time/Errors; SD: Serial Dotting Test; PHES Psychometric Hepatic Encephalopathy Score. 
 
€PHES score range for UK identification cohort is standardized so the original normative dataset had a mean of zero and a SD of one. 
 
Significance of the difference between the reference population and the various patient subgroups; ^ p<0.05; ^^ p<0.01; ^^^ p<0.001 
Significance of the difference between patients with a PHES score >0 and those with a PHES score 0 to -2; * p<0.05; ** p<0.001 
Significance of the difference between patients with a PHES score 0 to -2 and those with a PHES score -2 to -4; # p<0.05; ## p<0.001 
Significance of the difference between patients with a PHES score -2 to -4 and those with a PHES score <-4; & p<0.05; && p<0.001 
 
Study population  
(n) 
Age 
(yr) 
Male 
n (%)  
MELD 
score 
 
NCT A 
(s) 
NTC B 
(s) 
DS 
(n correct) 
SD 
(s) 
LTT 
(s) 
LTE 
(n errors) 
 
PHES 
score
€
 
Reference 
(98) 
39.6±15.5 
(17-75) 
52 
(53.1) 
 
        
Cirrhosis:  
All 
(264) 
55.7±10.1^^^ 
(24-81) 
 
172
^
 
(65.2) 
 
13.1±5.7 
(6-36) 
54.8±46.7 
(16-480) 
149.2±103.7 
(22-480) 
34.8±13.7 
(0-80) 
68.5±36.6 
(29-333) 
104.5±56.2 
(25-431) 
60.5±59.1 
(0-389) 
-1.5±1.5 
(-7 to 2) 
Cirrhosis:  
PHES >0 
(42) 
54.4±8.9^^ 
(39-77) 
27 
(64.3) 
 
10.1±3.1 
(6-19) 
27.8±8.9 
(16-68) 
 
61.8±24.4 
(22-148) 
 
51.6±8.7 
(30-80) 
 
41.6±7.6 
(29-65) 
 
71.7±26.6 
(25-145) 
 
39.6±35.3 
(3-138) 
 
0.6±0.5 
(0 to 2) 
 
Cirrhosis:  
PHES 0 to -2 
(132) 
55.1±10.2^^ 
(24-81) 
90 
(68.2) 
 
12.7±5.9** 
(6-32) 
 
42.4±16.7** 
(18-152) 
 
113.0±57.7** 
(42-400) 
 
38.0±9.1** 
(15-63) 
 
57.2±17.1** 
(31-111) 
 
90.6±35.9* 
(25-213) 
 
47.4±38.1 
(2-197) 
 
-1.0±0.5** 
(-2 to 0) 
 
Cirrhosis:  
PHES -2 to -4 
(75) 
57.5±11.3^^ 
(26-81) 
46 
(61.3) 
 
14.4±5.8**
#
 
(6-36) 
 
69.1±32.4**
##
 
(30-233) 
 
223.4±104.7**
##
 
(73-480) 
 
24.4±8.1**
##
 
(0-42) 
 
84.7±28.4**## 
(48-202) 
 
125.2±55.6**## 
(41-360) 
 
71.9±52.8**# 
(0-211) 
 
-2.8±0.5**## 
(-4 to-2) 
 
Cirrhosis:  
PHES <-4 
(15) 
55.3±6.3^^ 
(46-69) 
9 
(60.0) 
18.4±4.4**
##&
 
(13-26) 
167.5±119.5**
##&
 
(64-480) 
342.3±79.4**
##
 
(220-480) 
11.7±7.4**
##&&
 
(3-29) 
162.6±60.8**##& 
(83-333) 
214.4±92.7**##& 
(103-431) 
177.8±123.5**##& 
(35-389) 
-4.9±0.8**##&& 
(-7 to -4) 
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Table 2: Electroencephalogram functional connectivity in the patient discovery population, by PHES performance.  
 
Study population 
(n) 
Delta 
(1-3.5 Hz) 
Theta 
(4-8 Hz) 
Alpha 
(8.5-13 Hz) 
Beta 
(13.5-32.0 Hz) 
Reference population 
(98) 
0.1440.001 
(0.142-0.147) 
0.1030.002 
(0.100-0.106) 
0.1540.003 
(0.148-0.161) 
0.0700.001 
(0.068-0.072) 
     
Cirrhosis: all 
(264) 
0.1390.001
^^^
 
(0.137-0.140) 
0.1100.001
^^^
 
(0.108-0.112) 
0.1340.002
^^^
 
(0.130-0.138) 
0.0650.001
^^^
 
(0.064-0.066) 
     
Cirrhosis: PHES score >0 
(42) 
0.1390.002
^
 
(0.136-0.143) 
0.1040.002 
(0.100-0.109) 
0.1470.005 
(0.137-0.157) 
0.0680.001 
(0.065-0.070) 
     
Cirrhosis: PHES score 0 to -2 
(132) 
0.1390.001
^^
 
(0.137-0.141) 
0.1070.001
^
 
(0.105-0.110) 
0.1390.003
^^
 
(0.133-0.145) 
0.0660.001
^^
 
(0.065-0.068) 
     
Cirrhosis; PHES score -2 to -4 
(75) 
0.1370.001
^^^
 
(0.135-0.140) 
0.1160.002
^^^**###
 
(0.112-0.119) 
0.1220.004
^^^**###
 
(0.115-0.130) 
0.0630.001
^^^*##
 
(0.061-0.065) 
     
Cirrhosis: PHES score <-4 
(15) 
0.1440.003 
(0.137-0.150) 
0.1230.004
^^^**###
 
(0.115-0.131) 
0.1080.008
^^^**###
 
(0.091-0.124) 
0.0600.002
^^^*#
 
(0.056-0.065) 
 
Data are expressed as estimates from linear mixed models ± SEM (95% CI).  
 
PHES Psychometric Hepatic Encephalopathy Score.  
 
Significance of the difference between the reference population and the various patient subgroups; ^ p<0.05; ^^ p<0.01; ^^^ p<0.001 
Significance of the difference between patients with PHES score (>0) and the other patient subgroups; * p<0.01 ** p<0.001 
Significance of the difference between patients with PHES score (0 to -2) and the other patient subgroups; # p<0.05; ## p<0.01; ### p<0.001 
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Table 3: Univariate and multivariate linear mixed effect models of functional cortical connectivity against psychometric performance and liver  
 
Disease aetiology and severity, by frequency bands. 
 
 Data are expressed as estimates from linear mixed effect models ± SEM.  
Frequency 
band 
Assessment variable Univariate 
 
Multivariate 
 
Coefficient P-value Coefficient P-value 
Delta 
(1-3.5 Hz) 
Psychometric performance (PHES) -0.0007±0.0005 0.16 -0.0010±0.0005 0.048 
Liver disease severity (MELD) -0.0001±0.0001 0.34 -0.0003±0.0001 0.011 
Liver disease aetiology (alcohol/non-alcohol) 0.0009±0.0017 0.59 0.0005±0.0016 0.74 
     
Theta 
(4-8Hz) 
Psychometric performance (PHES) -0.0039±0.0007 <0.001 -0.0032±0.0008 <0.001 
Liver disease severity (MELD) 0.0008±0.0002 <0.001 0.0004±0.0002 0.058 
Liver disease aetiology (alcohol/non-alcohol) -0.0002±0.0027 0.94 -0.0010±0.0025 0.69 
     
Alpha 
(8.5-13 Hz) 
Psychometric performance (PHES) 0.0084±0.0013 <0.001 0.0066±0.0013 <0.001 
Liver disease severity (MELD) -0.0020±0.0003 <0.001 -0.0013±0.003 <0.001 
Liver disease aetiology (alcohol/non-alcohol) 0.0058±0.0047 0.22 0.0053±0.0041 0.20 
     
Beta 
(13.5-32 Hz) 
Psychometric performance (PHES) 0.0011±0.0003 <0.001 0.0011±0.0003 <0.001 
Liver disease severity (MELD) -0.0001±0.001 0.066 -0.0001±0.0001 0.96 
Liver disease aetiology (alcohol/non-alcohol) 0.0012±0.0001 0.22 0.0006±0.0009 0.50 
